Log In

Resource Explorer

Help

FUNDING CANCER - Clinical Characterization of Cancer Therapy-Induced Adverse Sequelae and Mechanism-Based Interventional Strategies

Visit Website Add to Calendar 2024-11-12T05:00:00 2027-10-06T03:59:00 FUNDING CANCER - Clinical Characterization of Cancer Therapy-Induced Adverse Sequelae and Mechanism-Based Interventional Strategies<p><strong>Sponsor:</strong> NIH</p> <p><strong>Description:</strong> The purpose of this NIH NOFO is to promote research studies designed to address adverse sequelae of cancer therapies that persist and become chronic co-morbidities or develop as delayed posttreatment effects. This opportunity supports basic, translational, and clinical research projects that seek to identify the mechanisms of therapy-induced adverse sequelae, clinically characterize the adverse sequelae, and translate the mechanistic understanding into therapeutic approaches to prevent or minimize the development of long-term sequelae.</p> <ul> <li><strong>Applications Due:</strong><ul> <li>February 5, 2025</li> <li>June 5, 2025</li> <li>October 5, 2025</li> <li>February 5, 2026</li> <li>June 5, 2026</li> <li>October 5, 2026</li> <li>February 5, 2027</li> <li>June 5, 2027</li> <li>October 5, 2027</li> </ul> </li> </ul> <p>To view all current UVACCC funding opportunities, please click <a href="https://uvacancercenter.infoready4.com/" target="_blank">here.</a></p> <p>For all open cancer-related funding opportunities, please click <a href="https://portal.ithriv.org/#/search/filter?query=Cancer&showPastEvents=false&Type=Funding%20Resource">here.</a></p>OnlineUTC
Location: Online
November 12, 2024 5:00 AM UTC – October 6, 2027 3:59 AM UTC

Sponsor: NIH

Description: The purpose of this NIH NOFO is to promote research studies designed to address adverse sequelae of cancer therapies that persist and become chronic co-morbidities or develop as delayed posttreatment effects. This opportunity supports basic, translational, and clinical research projects that seek to identify the mechanisms of therapy-induced adverse sequelae, clinically characterize the adverse sequelae, and translate the mechanistic understanding into therapeutic approaches to prevent or minimize the development of long-term sequelae.

  • Applications Due:
    • February 5, 2025
    • June 5, 2025
    • October 5, 2025
    • February 5, 2026
    • June 5, 2026
    • October 5, 2026
    • February 5, 2027
    • June 5, 2027
    • October 5, 2027

To view all current UVACCC funding opportunities, please click here.

For all open cancer-related funding opportunities, please click here.

Creator Organization University of Virginia
Categories
PROPOSE > FUNDING RESOURCES > Federal and State Funding
Website https://grants.nih.gov/grants/guide/pa-files/PAR-25-145.html

Attachments

There are no files to display.